Skip to content

National Study on the Prevalence of Catheter-Related Venous Thrombosis

National Study on the Prevalence of Catheter-Related Venous Thrombosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07643246
Acronym
TROMBO
Enrollment
500
Registered
2026-06-11
Start date
2026-05-25
Completion date
2026-06-19
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombosis, Venous Catheterization

Brief summary

The aim is to determine the prevalence of catheter-related thrombosis (CRT) in hospitalized patients carrying PICC, FICC, CICC, and midline catheters through a multicenter, standardized prevalence study. To achieve this, a cross-sectional study with prospective data collection will be conducted, including, through consecutive sampling to minimize selection bias, all hospitalized patients over 18 years of age from both general wards and critical care units who have had one of these catheters in place for at least 7 days. During data collection, an ultrasound examination of the catheter insertion site will be performed in order to rule out the presence of thrombotic complications.

Interventions

None listed

Sponsors

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Lead SponsorOTHER
Hospital del Mar Research Institute (IMIM)
CollaboratorOTHER
Althaia Xarxa Assistencial Universitària de Manresa
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All hospitalized patients aged ≥18 years from all hospital wards, including critical care units, who are carriers of a midline, FICC, PICC, or CICC catheter with a dwell time of at least 7 days will be included.

Exclusion criteria

* Patients who do not provide informed consent for the ultrasound assessment.

Design outcomes

Primary

MeasureTime frameDescription
Overall prevalence of catheter-related thrombosisFrom the beginning of the cutoff to the end of the cutoff at 4 weeksNumber of patients with CRT / total number of patients evaluated) × 100

Secondary

MeasureTime frameDescription
Symptomatic CRTFrom the beginning of the cutoff to the end of the cutoff at 4 weeks(Number of CRT cases with ≥1 clinical sign / total number of CRT cases) × 100
Asymptomatic CRTFrom the beginning of the cutoff to the end of the cutoff at 4 weeks(Number of CRT cases without clinical signs / total number of CRT cases) × 100
Superficial CRTFrom the beginning of the cutoff to the end of the cutoff at 4 weeksNumber of superficial CRT cases / total number of CRT cases) × 100
Deep CRTFrom the beginning of the cutoff to the end of the cutoff at 4 weeksNumber of deep CRT cases / total number of CRT cases) × 100
Prevalence by responsible serviceFrom the beginning of the cutoff to the end of the cutoff at 4 weeks(Number of CRT cases in each service category / total number of patients evaluated in that service) × 100
Time from implantation to CRT diagnosisFrom the beginning of the cutoff to the end of the cutoff at 4 weeksMean, SD, median, and IQR (interquartile range) of elapsed days
Distribution by implanting operatorFrom the beginning of the cutoff to the end of the cutoff at 4 weeksNumber of CRT cases by implanting operator / total number of CRT cases × 100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026